Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Ideal results are achieved after multiple sessions but may require a long-term maintenance plan
And the $50 monthly price is much lower than Medicare patients currently pay out of pocket for GLP-1 drugs covered under Part D for treatment of conditions other than obesity
The baseline HbA1c in the tirzepatide arms was 8.52%8.59% and 8.50% in the study arm receiving insulin glargine
Medication continues monthly at $255+ based on your plan
A growing body of evidence suggests that GLP-1 receptor agonists, a class of medications commonly used to treat diabetes and obesity, may play an important role in managing hidradenitis suppurativa (HS), a chronic and often debilitating skin condition
US$ 28.41
US$ 25.73
US$ 20.42
US$ 26.72
US$ 27.85
